Phase I/II trial of oral UFT/Leucovorin (LV) and paclitaxel (P) in the second line treatment of patients (PTS) with metastatic breast cancer (MBC)

被引：0
|
作者：
Klaassen, U [1 ]
Lang, S [1 ]
Borquez, D [1 ]
Oberhoff, C [1 ]
Benner, S [1 ]
Harstrick, A [1 ]
Seeber, S [1 ]
机构：
[1] Univ Essen Gesamthsch, W German Canc Ctr, Dept Int Med Canc Res, Essen, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81710-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1294
引用
收藏
页码：S322 / S323
页数：2
相关论文
共 50 条
  • [41] Phase I study of an all-oral combination of vinorelbine (VRL) and cyclophosphamide (Ctx) as second line treatment in patients with metastatic breast cancer (MBC)
    ten Tije, AJ
    Lieverst, J
    Seynaeve, C
    Schornagel, JH
    Brandely, M
    Blanchot, G
    ter Steeg, JD
    Verweij, J
    Schellens, JHM
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S42 - S42
  • [42] Phase II study of oxaliplatin, UFT, and leucovorin in patients with metastatic gastric cancer
    Ester J. M. Siemerink
    Annemieke F. J. Drenth
    Nanno H. Mulder
    John T. M. Plukker
    Geke A. P. Hospers
    Gastric Cancer, 2010, 13 : 95 - 100
  • [43] Phase I/II trial of ixabepilone (Ixa) and dasatinib (D) for treatment of metastatic breast cancer (MBC)
    Schwartzberg, Lee S.
    Blakely, Laura J.
    Schnell, Frederick
    Christianson, David
    Andrews, Michael
    Johns, Amanda
    Walker, Mark
    CANCER RESEARCH, 2011, 71
  • [44] Phase I experience - Paclitaxel, UFT, and calcium folinate in metastatic breast cancer
    Dickson, NR
    Nicholson, BP
    Hande, K
    Blanke, C
    Johnson, D
    Cohen, A
    ONCOLOGY-NEW YORK, 1999, 13 (07): : 69 - 70
  • [45] Oral Vinorelbine in Combination With Capecitabine as a First Line Treatment in Patients (pts) With Metastatic Breast Cancer (MBC) Previously Treated With Anthracyclines ± Taxanes - Preliminary Results of a Multicentric Phase II Trial in Egypt
    Kandil, A.
    Hamada, E.
    Moawad, M.
    El Arab, L. Ezz
    Metwalli, H.
    Bathiouny, M.
    Mourad, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S351 - S351
  • [46] Final results of gemcitabine (G) and epirubicin (E) phase II trial in metastatic breast cancer (MBC) patients (pts).
    Fumoleau, P
    Viens, P
    Dieras, V
    Pujade-Lauraine, E
    Serin, D
    Petit, T
    Espie, M
    Kayitalire, L
    Robert, C
    Pouillart, P
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S90 - S90
  • [47] Phase II trial of weekly docetaxel (DOC) and prolonged capecitabine (C) in metastatic breast cancer (MBC) patients (pts).
    Shapiro, CL
    Ramaswamy, B
    Rhoades, C
    Kendra, K
    Allen, J
    Hauger, M
    Loughlin, H
    Moore, T
    Villalona, M
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S203 - S203
  • [48] Oral Gossypol in the Treatment of Patients with Refractory Metastatic Breast Cancer: A Phase I/II Clinical Trial
    Catherine Van Poznak
    Andrew D. Seidman
    Marcus M. Reidenberg
    Mark M. Moasser
    Nancy Sklarin
    Kimberly Van Zee
    Patrick Borgen
    Marc Gollub
    Doreen Bacotti
    T-J Yao
    Renny Bloch
    Monica Ligueros
    Martin Sonenberg
    Larry Norton
    Clifford Hudis
    Breast Cancer Research and Treatment, 2001, 66 : 239 - 248
  • [49] Oral gossypol in the treatment of patients with refractory metastatic breast cancer: A phase I/II clinical trial
    Van Poznak, C
    Seidman, AD
    Reidenberg, MM
    Moasser, MM
    Sklarin, N
    Van Zee, K
    Borgen, P
    Gollub, M
    Bacotti, D
    Yao, TJ
    Bloch, R
    Ligueros, M
    Sonenberg, M
    Norton, L
    Hudis, C
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 66 (03) : 239 - 248
  • [50] Correlative biomarkers in a phase II study of dasatinib (D) and weekly (w) paclitaxel (P) for patients (Pts) with metastatic breast carcinoma (MBC)
    Morris, P. G.
    Chang, J. C.
    Abbruzzi, A.
    Patil, S.
    Modi, S.
    Seidman, A. D.
    Sklarin, N. T.
    Norton, L.
    Hudis, C.
    Fornier, M. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345